Community EP024 - Past, Present, and Future of Riluzole in Acute SCI with Dr. Michael Fehlings
SCI Science Perspectives · American Spinal Injury Association
Audio is streamed directly from the publisher (content.rss.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join us this episode for a conversation with Dr. Michael Fehlings, the most cited neurosurgeon ever on the topic of spinal cord injury (https://doi.org/10.1038/s41393-021-00691-9), for a conversation about the pharmaceutical agent riluzole for the treatment of acute spinal cord injury (SCI). Dr. Fehlings walks us through the past, present, and future of this drug that has proven efficacy in other neurological conditions and that might serve an important role in initial phases of treating SCI. We trust you'll enjoy this conversation about riluzole from the source of a principal investigator physician-scientist studying it from its inauguration in SCI.